1-anilino-8-naphthalenesulfonate has been researched along with Acromegaly in 4 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Acromegaly: A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Objectives The aim of the study was to evaluate circulating insulin-like growth factor-1 (IGF-1), feline pancreas-specific lipase (fPLI) and total thyroxine (TT4) concentrations and urinary corticoid-to-creatinine ratio (UCCR) as indicators for the prevalence of acromegaly, pancreatitis, hyperthyroidism and hypercortisolism in cats with diabetes mellitus." | 7.85 | Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands. ( Kooistra, HS; Prins, M; Reusch, CE; Riond, B; Schaefer, S; Steiner, JM; Suchodolski, JS; Zini, E, 2017) |
| "Objectives The aim of the study was to evaluate circulating insulin-like growth factor-1 (IGF-1), feline pancreas-specific lipase (fPLI) and total thyroxine (TT4) concentrations and urinary corticoid-to-creatinine ratio (UCCR) as indicators for the prevalence of acromegaly, pancreatitis, hyperthyroidism and hypercortisolism in cats with diabetes mellitus." | 3.85 | Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands. ( Kooistra, HS; Prins, M; Reusch, CE; Riond, B; Schaefer, S; Steiner, JM; Suchodolski, JS; Zini, E, 2017) |
| "Gross hyperlipidemia revealed type V hyperlipoproteininemia, according to agarose gel electrophoretic pattern of serum lipoprotein." | 1.26 | Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes. ( Haba, T; Kawato, M; Mabuchi, H; Nakabayashi, H; Takeda, R; Tatami, R; Ueda, K, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schaefer, S | 1 |
| Kooistra, HS | 1 |
| Riond, B | 1 |
| Suchodolski, JS | 1 |
| Steiner, JM | 1 |
| Prins, M | 1 |
| Zini, E | 1 |
| Reusch, CE | 1 |
| Murase, T | 1 |
| Yamada, N | 1 |
| Ohsawa, N | 1 |
| Kosaka, K | 1 |
| Morita, S | 1 |
| Yoshida, S | 1 |
| Takeda, R | 1 |
| Tatami, R | 1 |
| Ueda, K | 1 |
| Haba, T | 1 |
| Kawato, M | 1 |
| Nakabayashi, H | 1 |
| Mabuchi, H | 1 |
| Tan, KC | 1 |
| Shiu, SW | 1 |
| Janus, ED | 1 |
| Lam, KS | 1 |
4 other studies available for 1-anilino-8-naphthalenesulfonate and Acromegaly
| Article | Year |
|---|---|
Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands.
Topics: Acromegaly; Adrenal Cortex Hormones; Animals; Cat Diseases; Cats; Creatinine; Cushing Syndrome; Diab | 2017 |
Decline of postheparin plasma lipoprotein lipase in acromegalic patients.
Topics: Acromegaly; Adult; Blood Glucose; Cholesterol; Female; Growth Hormone; Heparin; Humans; Insulin; Kin | 1980 |
Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes.
Topics: Acromegaly; Adult; Cholesterol; Growth Hormone; Hormones; Humans; Hyperlipidemias; Hyperlipoproteine | 1982 |
LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-I.
Topics: Acromegaly; Apolipoproteins; Biomarkers; Body Mass Index; Bromocriptine; Carrier Proteins; Cholester | 1997 |